Affordable Growth. Analyze the stocks which are showing good growth, decent profitability and health and are not overvalued from a fundamental perspective.
Taking everything into account, HALO scores 8 out of 10 in our fundamental rating. HALO was compared to 562 industry peers in the Biotechnology industry. HALO scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HALO is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make HALO suitable for value and growth and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 22.1% | ||
ROE | 100.64% | ||
ROIC | 23.44% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 55.1% | ||
PM (TTM) | 44.76% | ||
GM | 83.45% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 3.13 | ||
Debt/FCF | 3.04 | ||
Altman-Z | 5.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 8.39 | ||
Quick Ratio | 7.3 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 14.63 | ||
Fwd PE | 9.77 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 16.59 | ||
EV/EBITDA | 12.26 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |